Amyris, Inc. (AMRS) |
|
1.32 -0.13 (-8.97%)
|
03-24 16:00 |
|
Open: |
1.44 |
Pre. Close: |
1.45 |
|
High:
|
1.475 |
Low:
|
1.31 |
|
Volume:
|
3,311,677 |
Market Cap:
|
483(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:23:58 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.63 One year: 1.93 |
| Support: |
Support1: 0.99 Support2: 0.82 |
| Resistance: |
Resistance1: 1.4 Resistance2: 1.65 |
| Pivot: |
1.23  |
| Moving Average: |
MA(5): 1.34 MA(20): 1.22
MA(100): 1.68 MA(250): 2.36 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 81.4 %D(3): 86.3 |
| RSI: |
RSI(14): 49.9 |
| 52-week: |
High: 5.15 Low: 0.99 |
| Average Vol(K): |
3-Month: 5,623 (K) 10-Days: 4,776 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AMRS ] has closed below upper band by 28.5%. Bollinger Bands are 43.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.48 - 1.48 |
1.48 - 1.49 |
|
Low:
|
1.29 - 1.3 |
1.3 - 1.31 |
|
Close:
|
1.31 - 1.32 |
1.32 - 1.33 |
|
Company Description |
|
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. |
Headline News |
Fri, 24 Mar 2023
Basic Materials Stocks Making Moves Friday: DNMR, BAK, HCC, KALU, AMRS, LOOP, CMCL, MTA - InvestorsObserver
Thu, 23 Mar 2023
Do Analysts Agree Thursday on Amyris Inc (AMRS) Stock's Target Price? - InvestorsObserver
Wed, 22 Mar 2023
Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying? - Simply Wall St
Sun, 19 Mar 2023
Amyris, Inc. (NASDAQ:AMRS) Q4 2022 Earnings Call Transcript - Yahoo Finance
Thu, 16 Mar 2023
Amyris, Inc. (NASDAQ:AMRS) Short Interest Up 6.9% in February - MarketBeat
Thu, 16 Mar 2023
LivePerson, Amyris And Other Big Stocks Moving Lower In ... - Benzinga
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Basic Materials |
| Industry: Specialty Chemicals |
| Shares Out. |
366 (M) |
| Shares Float |
258 (M) |
|
% Held by Insiders
|
29.7 (%) |
|
% Held by Institutions
|
35.4 (%) |
|
Shares Short
|
51,680 (K) |
|
Shares Short P.Month
|
46,400 (K) |
Stock Financials |
|
EPS
|
-1.16 |
|
EPS Est Next Qtl
|
-0.16 |
|
EPS Est This Year
|
-3.32 |
|
EPS Est Next Year
|
-1.85 |
|
Book Value (p.s.)
|
-1.35 |
|
Profit Margin (%)
|
-195.9 |
|
Operating Margin (%)
|
-219.7 |
|
Return on Assets (ttm)
|
-41.7 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
17 |
|
Gross Profit (p.s.)
|
-0.27 |
|
Sales Per Share
|
0.73 |
|
EBITDA (p.s.)
|
-1.58 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-526 (M) |
|
Levered Free Cash Flow
|
-385 (M) |
Stock Valuations |
|
PE Ratio
|
-1.14 |
|
PEG Ratio
|
-0.1 |
|
Price to Book value
|
-0.99 |
|
Price to Sales
|
1.79 |
|
Price to Cash Flow
|
-0.92 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2017-06-05 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
